This case describes percutaneous coronary intervention of a chronic total occlusion of the right coronary artery at the RV marginal bifurcation that was wire-uncrossable until plaque modification with side branch intravascular lithotripsy into the right ventricular marginal allowed crossing.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaccas.2024.103175 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-analysis.
J Soc Cardiovasc Angiogr Interv
January 2025
Yale Cardiovascular Research Group, Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Background: To understand the relative safety and efficacy of endovascular treatment modalities used for superficial femoral artery (SFA) disease, we performed a network meta-analysis to compare outcomes between percutaneous transluminal angioplasty (PTA), atherectomy (A), bare metal stent (BMS), brachytherapy/radiotherapy, covered stent graft (CSG), cutting balloon angioplasty (CBA), drug-coated balloon (DCB), drug-eluting stent (DES), and intravascular lithotripsy (L).
Methods: We performed a systematic literature search of PubMed from January 2000 to January 2023 to identify randomized trials comparing endovascular interventions for the treatment of SFA disease. The primary end points were technical success and 12-month primary patency.
Enhanced intravascular lithotripsy (IVL) with ultrasound-shockwave catheter.
Med Eng Phys
March 2025
Suzhou Institute of Biomedical Engineering and Technology (SIBET), Chinese Academy of Sciences, Suzhou 215163, China. Electronic address:
Intravascular shockwave lithotripsy (IVL) is an effective treatment for vascular calcification. Previous studies suggest that ultrasound can enhance the efficiency of extracorporeal shockwave lithotripsy (ESWL) by mitigating the bubble shielding effect. We developed a novel ultrasound-shockwave catheter that combines flowing liquid and ultrasound to suppress bubble shielding and enhance lithotripsy efficiency.
View Article and Find Full Text PDFSide-Branch Intravascular Lithotripsy for an Uncrossable Chronic Total Occlusion.
JACC Case Rep
March 2025
Hamilton Health Sciences, McMaster University, Hamilton, Canada; Population Health Research Institute, Hamilton, Canada. Electronic address:
This case describes percutaneous coronary intervention of a chronic total occlusion of the right coronary artery at the RV marginal bifurcation that was wire-uncrossable until plaque modification with side branch intravascular lithotripsy into the right ventricular marginal allowed crossing.
View Article and Find Full Text PDFIliac Arterial Intervention.
Interv Cardiol Clin
April 2025
Interventional Cardiology, Vascular and Endovascular Medicine, Piedmont Heart Institute, 275 Collier Road Suite 2065, Atlanta, GA 30309, USA. Electronic address:
Peripheral arterial disease affects a large patient population, and a large percentage of these patients have evidence of aortoiliac occlusive disease. This review discusses the evaluation and characterization of iliac lesions as well as the associated interventional procedures focusing on techniques, device choice, potential complications, and postprocedural care. We discuss stent choice and studies aimed at analyzing the outcomes associated with each type as well as a brief discussion of intravascular lithotripsy which is quickly becoming a popular plaque modifier in endovascular procedures.
View Article and Find Full Text PDFIntravascular brachytherapy for the management of drug-eluting in-stent restenosis.
J Invasive Cardiol
March 2025
Northwell Health at Lenox Hill Hospital, New York, New York; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, New York.
Objectives: This study aimed to evaluate the utilization and clinical outcomes of coronary intravascular brachytherapy (IVBT) as a treatment modality for multilayer in-stent restenosis (ISR).
Methods: This multicenter study retrospectively analyzed 101 patients who presented for percutaneous intervention of recurrent drug-eluting stent ISR using IVBT from 2019 to 2023. The primary outcome assessed was target lesion revascularization (TLR) at 1 year.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!